Federated Hermes
CSBR icon

Federated Hermes’s Champions Oncology CSBR Stock Holding History

Federated Hermes’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,894
Closed -$59K – 2219
2021
Q3 		$59K Buy
+5,894
New +$60K ﹤0.01% 1843
2019
Q1 		– Sell
-657
Closed -$5K – 2159
2018
Q4 		$5K Buy
657
+157
+31% +$1.8K ﹤0.01% 1975
2018
Q3 		$9K Buy
+500
New +$4.45K ﹤0.01% 1968

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

Federated Hermes's CSBR Position: Q4 2021 in Review

Federated Hermes sold out of Champions Oncology (CSBR) in Q4 2021, closing a stake of 5,894 shares — an estimated $59K sold.

Federated Hermes first reported a position in CSBR in Q3 2018 and held it in 3 quarters. The position peaked at $59K in Q3 2021. 31 funds tracked by Wall St. Rank hold CSBR as of Q4 2021.

  • Federated Hermes reported no remaining Champions Oncology position as of Q4 2021 after selling out during the quarter.
  • Federated Hermes sold 5,894 Champions Oncology shares in Q4 2021, an estimated $59K.
  • Federated Hermes first reported a position in Champions Oncology in Q3 2018 and held it in 3 quarters.
  • Federated Hermes's Champions Oncology position peaked at $59K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2021.

Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.